There is a significant Indian population affected with diabetes for both Type 1 and Type 2 Diabetes Mellitus, where Insulin ...

Global pharma company Lupin announced the acquisition of Huminsulin in India from Eli Lilly and Company (Lilly), aiming to ...

Nilesh Gupta, Managing Director of Lupin, emphasised that this acquisition aligns with the company’s commitment to expanding ...

Lupin Ltd. acquires Huminsulin range from Eli Lilly, strengthening its position in the Indian diabetes market.

Huminsulin is used for adult and pediatric patient with Type 1 and Type 2 diabetes mellitus that aids in regulation of blood ...

The stock of the pharmaceutical company, Lupin is quoting higher for the sixth straight trading day; it has rallied 10 per ...

Mumbai: Global pharma major Lupin Limited has announced the acquisition of Huminsulin in India from Eli Lilly and Company to ...

Driven by higher sales, pharmaceutical giant Lupin Ltd. reported a strong 74.1 per cent year-over-year increase in its ...

Lupin announced the acquisition of Huminsulin in India from Eli Lilly and company (Lilly) to further enhance its diabetes portfolio for an unspecified amount.

Global pharma major Lupin Limited announced the acquisition of Huminsulin in India from Eli Lilly and Company (Lilly) to further enhance its diabetes portfolio. Lupin has been marketing the Huminsulin ...